Skip to content

ABBOTT

Active
Public limited companyfounded 1948active for 78 yearsAvenue Einstein 14, 1300 Wavre, BelgiumKBO/BCE: BE 0403.044.007
Summary

ABBOTT has been active since 1948 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.10bn and a net result of €369.8m. Equity remains stable across the filed financial years (±0.3% per year). Its solvency ranks better than 93% of 6,105 sector peers (NACE 46, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Financials · financial year 2025, full format

Turnover
€105.6m▲ 7.4%
2024 · €98.3m
EBIT margin
4.1%▲ 1.8pp
2024 · 2.3%
Net result
€369.8m
2024 · -€5.4m
Working capital
-€187.9m▼ 0.3%
2024 · -€187.4m
Trend over the years

2021 to 2025, 5 financial years 2019 to 2025, 6 financial years

After the dip in 2022 the operating result has climbed three years in a row; 2025 is 94% above 2024 and is the highest result in the available series.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Turnover€105.6m 2025 Operating result€4.3m 2025 Net result€369.8m 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA), Staff (FTE).

Every figure with its change against the financial year before
favourable unfavourable
Line201920212022202320242025
Turnover€78.8m-€94.1m-€91.4m▼ 2.9%€93.6m▲ 2.5%€98.3m▲ 5.0%€105.6m▲ 7.4%
Operating result€1.7m-€1.7m-€0.3m▼ 80.1%€2.1m▲ 533%€2.2m▲ 5.3%€4.3m▲ 94.0%
Net result€496.5m-€66.2mabove the sector's middle half-€217.8mabove the sector's middle half▲ 229%-€4.3mbelow the sector's middle half-€5.4mbelow the sector's middle half▼ 26.5%€369.8mabove the sector's middle half
EBIT margin2.2%-1.8%-0.4%▼ 1.4pp2.3%▲ 1.9pp2.3%=4.1%▲ 1.8pp
Equity€2,140.3m-€2,142.5mabove the sector's middle half-€2,114.2mabove the sector's middle half▼ 1.3%€2,109.9mabove the sector's middle half▼ 0.2%€2,108.1mabove the sector's middle half▼ 0.1%€2,104.8mabove the sector's middle half▼ 0.2%
Total assets€3,379.0m-€2,326.6mabove the sector's middle half-€2,328.8mabove the sector's middle half▲ 0.1%€2,335.8mabove the sector's middle half▲ 0.3%€2,339.1mabove the sector's middle half▲ 0.1%€2,338.1mabove the sector's middle half=
Debt€1,238.2m-€183.7m-€214.3m▲ 16.6%€225.2m▲ 5.1%€230.1m▲ 2.2%€232.1m▲ 0.9%
Working capital-€150.2m--€152.3mbelow the sector's middle half--€181.8mbelow the sector's middle half▼ 19.4%-€185.6mbelow the sector's middle half▼ 2.1%-€187.4mbelow the sector's middle half▼ 0.9%-€187.9mbelow the sector's middle half▼ 0.3%
Solvency63.3%-92.1%above the sector's middle half-90.8%above the sector's middle half▼ 1.3pp90.3%above the sector's middle half▼ 0.5pp90.1%above the sector's middle half▼ 0.2pp90.0%above the sector's middle half▼ 0.1pp
Current ratio0.88-0.17below the sector's middle half-0.15below the sector's middle half▼ 0.020.17below the sector's middle half▲ 0.030.18below the sector's middle half▲ 0.010.19below the sector's middle half=
Return on assets (ROA)14.7%-2.8%within the sector's middle half-9.4%within the sector's middle half▲ 6.5pp-0.2%below the sector's middle half▼ 9.5pp-0.2%below the sector's middle half=15.8%above the sector's middle half▲ 16.0pp
Staff (FTE)85.7-82.5above the sector's middle half-87.3above the sector's middle half▲ 5.8%775above the sector's middle half▲ 788%75.8above the sector's middle half▼ 90.2%71.2above the sector's middle half▼ 6.1%
above within below the middle half of NACE 46, Wholesale trade: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.34bn
Fixed assets €2.30bn ▼ 0.1%
Current assets €43.0m ▲ 3.1%
Equity and liabilities €2.34bn
Equity €2.10bn ▼ 0.2%
Provisions €1.2m ▲ 21.9%
Debt €232.1m ▲ 0.9%
Debt's share of the balance-sheet total rises from 9.8% to 9.9%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
EBITDA
€6.8m▲
2024 · €4.9m
Cash flow
€372.3m▲
2024 · -€2.7m
Quick ratio
0.18▲
2024 · 0.18
Debt to equity
0.11▲
2024 · 0.11
ROE
17.6%▲
2024 · -0.3%
Interest coverage
1.44▲
2024 · 0.65
Debt ≤ 1 year
€230.9m▲
2024 · €229.1m
Income taxes
-€840,128▼
2024 · €137,733
Staff costs
€13.7m▲
2024 · €13.0m
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 76 lines
Balance sheet Code20242025
Assets
Total assets20/58€2,339.1m€2,338.1m=
Fixed assets21/28€2,297.4m€2,295.1m▼
Intangible fixed assets21€0.2m€0.2m=
Tangible fixed assets22/27€16.0m€13.7m▼
Furniture and vehicles24€0.3m€0.3m▲
Other tangible fixed assets26€15.7m€13.4m▼
Assets under construction and advance payments27-€0.003m
Financial fixed assets28€2,281.2m€2,281.2m=
Affiliated companies280/1€2,280.1m€2,280.1m=
Participating interests280€2,280.1m€2,280.1m=
Other financial fixed assets284/8€1.1m€1.1m▼
Amounts receivable and cash guarantees285/8€1.1m€1.1m▼
Current assets29/58€41.7m€43.0m▲
Stocks and contracts in progress3€1.1m€0.7m▼
Stocks30/36€1.1m€0.7m▼
Goods purchased for resale34€1.1m€0.7m▼
Amounts receivable within one year40/41€37.8m€41.1m▲
Trade receivables40€37.6m€41.0m▲
Other amounts receivable41€0.2m€0.08m▼
Cash at bank and in hand54/58€2.6m€1.1m▼
Deferred charges and accrued income490/1€0.2m€0.2m▲
Equity and liabilities
Total equity and liabilities10/49€2,339.1m€2,338.1m=
Equity10/15€2,108.1m€2,104.8m▼
Contributions10/11€3,014.6m€2,645.2m▼
Capital10€3,014.6m€2,645.2m▼
Issued capital100€3,014.6m€2,645.2m▼
Reserves13€47.1m€47.1m=
Non-distributable reserves130/1€47.1m€47.1m=
Legal reserve130€47.1m€47.1m=
Other1319€0.001m€0.001m=
Profit (loss) carried forward14-€953.7m-€587.5m▲
Provisions and deferred taxes16€1.0m€1.2m▲
Provisions for liabilities and charges160/5€1.0m€1.2m▲
Other liabilities and charges164/5€1.0m€1.2m▲
Amounts payable17/49€230.1m€232.1m▲
Amounts payable within one year42/48€229.1m€230.9m▲
Trade debts44€15.5m€13.1m▼
Suppliers440/4€15.5m€13.1m▼
Taxes, remuneration and social security45€3.9m€5.2m▲
Taxes450/3€0.3m€1.2m▲
Remuneration and social security454/9€3.6m€4.0m▲
Other amounts payable47/48€209.7m€212.6m▲
Accrued charges and deferred income492/3€1.0m€1.2m▲
Income statement Code20242025
Operating income70/76A€100.0m€107.3m▲
Turnover70€98.3m€105.6m▲
Other operating income74€1.7m€1.7m▼
Operating charges60/66A€97.8m€103.0m▲
Goods for resale, raw materials and consumables60€71.8m€76.5m▲
Purchases600/8€70.9m€75.4m▲
Change in stocks: decrease (increase)609€0.9m€1.1m▲
Services and other goods61€9.9m€9.9m▼
Remuneration, social security and pensions62€13.0m€13.7m▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€2.7m€2.5m▼
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€0.2m-€0.2m▼
Provisions for liabilities and charges: additions (uses and reversals)635/8-€0.01m€0.2m▲
Other operating charges640/8€0.2m€0.3m▲
Non-recurring operating charges66A€0.003m€0.06m▲
Operating profit (loss)9901€2.2m€4.3m▲
Financial income75/76B€0.1m€369.5m▲
Recurring financial income75€0.1m€369.5m▲
Income from financial fixed assets750-€369.5m
Other financial income752/9€0.1m-
Non-recurring financial income76B-€0.006m
Financial charges65/66B€7.6m€4.8m▼
Recurring financial charges65€7.6m€4.8m▼
Debt charges650€7.6m€4.7m▼
Other financial charges652/9€0.03m€0.06m▲
Profit (loss) for the period before taxes9903-€5.3m€369.0m▲
Income taxes67/77€0.1m-€0.8m▼
Taxes670/3€0.1m-
Tax adjustments and reversals of tax provisions77-€0.8m
Profit (loss) for the period9904-€5.4m€369.8m▲
Profit (loss) for the period to be appropriated9905-€5.4m€369.8m▲
Appropriation of the result
Profit (loss) to be appropriated9906-€953.7m-€587.5m▲
Profit (loss) brought forward from the previous period14P-€948.3m-€957.3m▼
Social balance sheet
Average headcount (FTE)908775.871.2▼

The notes to these accounts (51 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line201920212022202320242025Change
Operating income70/76A€81.2m€95.8m€93.1m€95.6m€100.0m€107.3m▲ 7.3%
Turnover70€78.8m€94.1m€91.4m€93.6m€98.3m€105.6m▲ 7.4%
Other operating income74€2.3m€1.7m€1.7m€2.0m€1.7m€1.7m▼ 0.3%
Operating charges60/66A€79.4m€94.1m€92.8m€93.5m€97.8m€103.0m▲ 5.3%
Goods for resale, raw materials and consumables60€57.2m€72.1m€69.0m€65.6m€71.8m€76.5m▲ 6.6%
Purchases600/8---€64.7m€70.9m€75.4m▲ 6.4%
Change in stocks: decrease (increase)609-€0.1m€0.7m€0.6m€1.0m€0.9m€1.1m▲ 24.2%
Services and other goods61€6.6m€7.0m€7.1m€8.3m€9.9m€9.9m▼ 0.1%
Remuneration, social security and pensions62€13.1m€11.7m€13.5m€13.5m€13.0m€13.7m▲ 5.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€1.9m€2.1m€2.1m€2.5m€2.7m€2.5m▼ 7.6%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€0.07m€0.4m€0.09m€0.4m€0.2m-€0.2m-
Provisions for liabilities and charges: additions (uses and reversals)635/8€0.04m€0.1m-€0.08m€2.2m-€0.01m€0.2m-
Other operating charges640/8€0.2m€0.8m€1.0m€0.9m€0.2m€0.3m▲ 36.0%
Non-recurring operating charges66A€0.2m€0.02m€0.02m€0.002m€0.003m€0.06m▲ 1,991%
Operating profit (loss)9901€1.7m€1.7m€0.3m€2.1m€2.2m€4.3m▲ 94.0%
Financial income75/76B---€0.05m€0.1m€369.5m▲ 279,731%
Recurring financial income75€500.4m€65.1m€219.8m€0.05m€0.1m€369.5m▲ 279,726%
Income from financial fixed assets750€500.0m€65.0m€219.8m--€369.5m-
Income from current assets751€0.4m------
Other financial income752/9€0.04m€0.07m-€0.05m€0.1m--
Non-recurring financial income76B€0.01m€0.04m---€0.006m-
Financial charges65/66B€5.2m€0.4m€1.7m€7.0m€7.6m€4.8m▼ 37.1%
Recurring financial charges65€1.1m€0.4m€1.7m€7.0m€7.6m€4.8m▼ 37.1%
Debt charges650€0.7m€0.09m€0.6m€6.8m€7.6m€4.7m▼ 37.7%
Other financial charges652/9€0.3m€0.3m€1.2m€0.1m€0.03m€0.06m▲ 102%
Non-recurring financial charges66B€4.2m------
Profit (loss) for the period before taxes9903€496.9m€66.4m€218.4m-€4.8m-€5.3m€369.0m-
Income taxes67/77€0.4m€0.2m€0.6m-€0.5m€0.1m-€0.8m-
Taxes670/3€0.4m€0.2m€0.6m-€0.1m--
Tax adjustments and reversals of tax provisions77---€0.5m-€0.8m-
Profit (loss) for the period9904€496.5m€66.2m€217.8m-€4.3m-€5.4m€369.8m-
Profit (loss) for the period to be appropriated9905€496.5m€66.2m€217.8m-€4.3m-€5.4m€369.8m-
Line201920212022202320242025Change
Assets
Total assets20/58€3,379.0m€2,326.6m€2,328.8m€2,335.8m€2,339.1m€2,338.1m=
Fixed assets21/28€2,291.6m€2,295.9m€2,297.2m€2,296.8m€2,297.4m€2,295.1m▼ 0.1%
Intangible fixed assets21-€0.002m€0.002m€0.2m€0.2m€0.2m=
Tangible fixed assets22/27€12.4m€13.6m€14.9m€15.3m€16.0m€13.7m▼ 14.4%
Furniture and vehicles24€0.1m€0.1m€0.2m€0.3m€0.3m€0.3m▲ 12.3%
Other tangible fixed assets26€10.8m€13.5m€14.7m€15.0m€15.7m€13.4m▼ 14.8%
Assets under construction and advance payments27€1.4m----€0.003m-
Financial fixed assets28€2,279.3m€2,282.3m€2,282.3m€2,281.3m€2,281.2m€2,281.2m=
Affiliated companies280/1€2,278.6m€2,281.4m€2,281.4m€2,280.1m€2,280.1m€2,280.1m=
Participating interests280€2,278.6m€2,281.4m€2,281.4m€2,280.1m€2,280.1m€2,280.1m=
Other financial fixed assets284/8€0.7m€0.9m€1.0m€1.2m€1.1m€1.1m▼ 0.6%
Amounts receivable and cash guarantees285/8€0.7m€0.9m€1.0m€1.2m€1.1m€1.1m▼ 0.6%
Current assets29/58€1,087.3m€30.7m€31.6m€39.0m€41.7m€43.0m▲ 3.1%
Stocks and contracts in progress3€1.2m€2.4m€1.6m€2.7m€1.1m€0.7m▼ 43.0%
Stocks30/36€1.2m€2.4m€1.6m€2.7m€1.1m€0.7m▼ 43.0%
Goods purchased for resale34€1.2m€2.4m€1.6m€2.7m€1.1m€0.7m▼ 43.0%
Amounts receivable within one year40/41€1,083.5m€25.5m€27.7m€31.7m€37.8m€41.1m▲ 8.7%
Trade receivables40€21.1m€23.9m€27.5m€31.5m€37.6m€41.0m▲ 9.1%
Other amounts receivable41€1,062.3m€1.6m€0.3m€0.2m€0.2m€0.08m▼ 60.7%
Cash at bank and in hand54/58€2.4m€2.8m€2.2m€4.5m€2.6m€1.1m▼ 58.6%
Deferred charges and accrued income490/1€0.2m--€0.1m€0.2m€0.2m▲ 11.6%
Equity and liabilities
Total equity and liabilities10/49€3,379.0m€2,326.6m€2,328.8m€2,335.8m€2,339.1m€2,338.1m=
Equity10/15€2,140.3m€2,142.5m€2,114.2m€2,109.9m€2,108.1m€2,104.8m▼ 0.2%
Contributions10/11€3,325.7m€3,260.7m€3,014.6m€3,014.6m€3,014.6m€2,645.2m▼ 12.3%
Capital10€3,325.7m€3,260.7m€3,014.6m€3,014.6m€3,014.6m€2,645.2m▼ 12.3%
Issued capital100€3,325.7m€3,260.7m€3,014.6m€3,014.6m€3,014.6m€2,645.2m▼ 12.3%
Reserves13€32.9m€36.2m€47.1m€47.1m€47.1m€47.1m=
Non-distributable reserves130/1-€36.2m€47.1m€47.1m€47.1m€47.1m=
Legal reserve130€32.9m€36.2m€47.1m€47.1m€47.1m€47.1m=
Reserves not available under the articles1311€0.001m------
Other1319-€0.001m€0.001m€0.001m€0.001m€0.001m=
Profit (loss) carried forward14-€1,218.3m-€1,154.5m-€947.6m-€951.9m-€953.7m-€587.5m▲ 38.4%
Provisions and deferred taxes16€0.4m€0.5m€0.4m€0.8m€1.0m€1.2m▲ 21.9%
Provisions for liabilities and charges160/5€0.4m€0.5m€0.4m€0.8m€1.0m€1.2m▲ 21.9%
Pensions and similar obligations160€0.08m------
Other liabilities and charges164/5€0.3m€0.5m€0.4m€0.8m€1.0m€1.2m▲ 21.9%
Amounts payable17/49€1,238.2m€183.7m€214.3m€225.2m€230.1m€232.1m▲ 0.9%
Amounts payable within one year42/48€1,237.5m€183.0m€213.3m€224.6m€229.1m€230.9m▲ 0.8%
Trade debts44€10.7m€9.0m€9.8m€15.1m€15.5m€13.1m▼ 15.6%
Suppliers440/4€10.7m€9.0m€9.8m€15.1m€15.5m€13.1m▼ 15.6%
Taxes, remuneration and social security45€5.3m€5.2m€6.6m€4.5m€3.9m€5.2m▲ 34.3%
Taxes450/3€1.6m€1.5m€2.8m€0.8m€0.3m€1.2m▲ 284%
Remuneration and social security454/9€3.7m€3.6m€3.8m€3.8m€3.6m€4.0m▲ 13.0%
Other amounts payable47/48€1,221.6m€168.8m€196.9m€205.0m€209.7m€212.6m▲ 1.4%
Accrued charges and deferred income492/3€0.7m€0.7m€0.9m€0.5m€1.0m€1.2m▲ 22.3%
Line201920212022202320242025Change
Profit (loss) for the period9904€496.5m€66.2m€217.8m-€4.3m-€5.4m€369.8m-
+ Depreciation and write-downs630€1.9m€2.1m€2.1m€2.5m€2.7m€2.5m▼ 7.6%
Operating cash flow (approximation)€498.4m€68.3m€219.9m-€1.8m-€2.7m€372.3m-
Investment in fixed assets (approximation)---€3.4m-€2.1m-€3.4m-€0.2m▲ 93.8%
Change in cash---€0.6m€2.2m-€1.9m-€1.5m▲ 19.6%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 49 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 full format 03-07-2026 2026-00244956
31-12-2024 full format 12-12-2025 2025-00581178
31-12-2023 full format 10-07-2024 2024-00245182
31-12-2022 full format 05-07-2023 2023-00213064
31-12-2021 full format 23-08-2022 2022-20309821
31-12-2020 full format 27-07-2021 2021-42800478
31-12-2019 full format 23-09-2020 2020-55500164
31-12-2018 full format 30-12-2019 2019-77900550
31-12-2017 full format 27-09-2018 2018-66500521
31-12-2016 full format 29-06-2017 2017-25400270

Show all 49 filings

Similar companies · same sector, comparable size

Of the 1,868 active companies whose main activity is wholesale of pharmaceutical and medical goods (NACE 46460), figures are known for 1,117. 10 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts

7 awards · 2024 to 2026
CAPTEURS DE GLYCEMIE EN CONTINU
buyer: ASBL CHU HELORAMedical equipment and pharmaceuticalsawarded 14-05-2026€1.72bn3 tendersTED 713361-2026
Procédure ouverte pour la fourniture de capteurs et lecteurs de la glycémie pour le compte du SPF JUSTICE, Direction générale Etablissements Pénitentiaires – Service Soins de Santé Prisons - Pharmacie centrale: CSC n° 2026-2029 / Glycémie CGM - 1
buyer: FOD JustitieMedical equipment and pharmaceuticalsawarded 01-01-2026€664,1791 tenderTED 6155-2026
Automates de mesure du temps de coagulation (ACT)
buyer: ASBL CHU HELORALaboratory, optical and precision equipmentawarded 04-11-2025€346,4642 tendersTED 736205-2025
Raamovereenkomst voor het leveren van reagentia voor het uitvoeren van chemie- en immunochemie-analyses incl. toestellen in bruikleen: Het leveren van reagentia voor het uitvoeren van virale serologie-analyses incl. toestellen in bruikleen
buyer: Universitair Ziekenhuis GentMedical equipment and pharmaceuticalsawarded 18-02-2025€1.3m3 tendersTED 124214-2025
Raamcontract voor het leveren van reagentia voor ACT- en bloedgasmetingen, inclusief koppeling met het LIS via reeds aanwezige open middleware software, het leveren, plaatsen en in dienst stellen van toestellen in bruikleen: Reagentia voor ACT-metingen
buyer: Universitair Ziekenhuis GentMedical equipment and pharmaceuticalsawarded 28-02-2024€417,7602 tendersTED 125142-2025
Show 2 more contracts
Raamcontract voor het leveren van reagentia voor ACT- en bloedgasmetingen, inclusief koppeling met het LIS via reeds aanwezige open middleware software, het leveren, plaatsen en in dienst stellen van toestellen in bruikleen: Reagentia voor bloedgasmetingen
buyer: Universitair Ziekenhuis GentMedical equipment and pharmaceuticalsawarded 28-02-2024€47,0401 tenderTED 125142-2025
Lecteurs basal-bolus: CF11-23 - 1
buyer: Centre Hospitalier Bois de l'AbbayeLaboratory, optical and precision equipmentawarded 19-02-2024€20,6141 tenderTED 114906-2024

Source: TED (Tenders Electronic Daily), Publications Office of the European Union. Values as the buyer published them; for a framework agreement, a ceiling.